This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Gut microbiome and CAR-T therapy
Experimental Hematology & Oncology Open Access 19 November 2019
-
Could the menagerie of the gut microbiome really cure cancer? Hope or hype
Journal for ImmunoTherapy of Cancer Open Access 02 April 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rosenbaum L. Tragedy, perseverance, and chance—the story of CAR-T therapy. N Engl J Med 2017;377:1313–5.
Kuehn BM. The promise and challenges of CAR-T gene therapy. JAMA 2017;318:2167–9.
Imai C, Mihara K, Andreansky M, Nicholson IC, Pui CH, Geiger TL, et al. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia. 2004;18:676–84.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Abid, M.B. The revving up of CARs. Gene Ther 25, 162 (2018). https://doi.org/10.1038/s41434-018-0015-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41434-018-0015-x
This article is cited by
-
Could the menagerie of the gut microbiome really cure cancer? Hope or hype
Journal for ImmunoTherapy of Cancer (2019)
-
Gut microbiome and CAR-T therapy
Experimental Hematology & Oncology (2019)